CEFPIROME. LITERATURE REVIEW

• Main Author: N. V. Dmitrieva
• Format: Article
• Language: English
• Published: Paediatrician Publishers, LLC 2014-09-01
• Series: Pediatričeskaâ Farmakologiâ
• Subjects: cefpirome; cefepime; nosocomial infections; sepsis; febrile neutropenia; antibiotic resistance; treatment of gram-negative infections; 4th-generation cephalosporins
• Online Access: https://www.pedpharma.ru/jour/article/view/56

Researchers around the world acknowledge a continuing growth of antibiotic resistance. Thus, it is especially important to select from a wide range of antibacterial agents in the pharmaceutical market the ones appropriate for specific regional sensitivity, only in accordance with clearly defined indications and in order of priority for each specific case. The most frequently used are wide range drugs, including the 4th-generation cephalosporins active against gram-positive and gram-negative microbes and most anaerobes. This review is dedicated to a representative of this group – cefpirome. The authors indicate the primary indications for use thereof and present a comparative effectiveness analysis. Cefpirome is as effective as cefepime, which is important, particularly because of growth of bacterial resistance against the 3rd-generation cephalosporins. Its significant advantage is activity against several enterococci and anaerobes. Cefpirome penetrates various body tissues fairly well and establishes there bactericidal concentrations against most known clinically significant microbes. The trials have demonstrated clinical effectiveness of the drug for various nosocomial infections, such as sepsis (62-77%), febrile neutropenia (53-84%), intra-abdominal infections (83%), complicated urinary infections (100%) etc. The drug features low toxicity: it does not exceed the one in cefepime and the 3rd-generation cephalosporins, which makes it possible to use cefpirome as the drug of the 1st choice for severe hospital-acquired infections given its wide antibacterial range and clinical significance.